OCC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.17%

Insider Buying (Last 12 Months): A$14,769.12

Insider Selling (Last 12 Months): A$0.00

Orthocell Insider Trading History Chart

Orthocell Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 05/13/2020 01:00 AM ET

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

Click here for details,

Orthocell Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
11/20/2023	Fiona Wood	Insider	Issued	2,000,000	A$0.41	A$820,000.00
11/15/2023	John Wielen	Insider	Issued	250,000	A$0.37	A$91,250.00
11/7/2023	Paul Anderson	Insider	Issued	500,000	A$0.39	A$192,500.00
6/13/2023	Paul Anderson	Insider	Buy	9,907	A$0.36	A$3,516.99
6/9/2023	Paul Anderson	Insider	Buy	31,343	A$0.36	A$11,252.14
11/7/2022	Lars Lidgren	Insider	Buy	45,000	A$0.43	A$19,350.00
9/23/2021	Paul Anderson	Insider	Sell	435,273	A$0.48	A$208,495.77
4/6/2021	Lars Lidgren	Insider	Buy	9,000	A$0.54	A$4,860.00

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Click here for details,

SEC Filings (Institutional Ownership Changes) for Orthocell (ASX:OCC)

2.91% of Orthocell stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

669,530 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.14

Who are the company insiders with the largest holdings of Orthocell?: Orthocell's top insider investors include:
Fiona Wood (Insider)
John Wielen (Insider)
Lars Lidgren (Insider)
Paul Anderson (Insider)
Learn More about top insider investors at Orthocell.